Skip to main content
Clinical Trials/NCT05331508
NCT05331508
Completed
Not Applicable

Testing the Integration of Gender-based Violence First-line Response in Family Planning and Antenatal Care Services in Nigeria

Jhpiego39 sites in 1 country1,756 target enrollmentApril 6, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Gender-based Violence
Sponsor
Jhpiego
Enrollment
1756
Locations
39
Primary Endpoint
Percentage of clients that report receiving a family planning method from healthcare provider
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

To pilot and evaluate the integration of first-line response to gender- based violence (GBV), particularly intimate partner violence (IPV), sexual violence and reproductive coercion, within family planning (FP) and antenatal care (ANC) services at public health facilities in Ebonyi and Sokoto states in Nigeria.

GBV first-line response in the health setting includes screening , empowerment counseling, safety planning, and support to connect to additional services needed.

Detailed Description

This study seeks to: 1. Assess effectiveness of an integrated service delivery model (integration of GBV first-line response and empowerment counseling in standard of care FP or ANC services) in reducing on-going experience of intimate partner violence (IPV) and increasing utilization of modern contraceptive methods among clients. 1a. Assess effectiveness of the intervention in reducing IPV, increasing utilization of modern contraceptive methods, and improving safety and self-efficacy among clients seeking interval FP services. 1b. Assess effectiveness of the intervention in reducing IPV and improving safety and self-efficacy to seek GBV care among clients seeking ANC services. 2. Explore factors influencing feasibility, acceptability and ability to implement GBV first-line response as part of FP and ANC services.

Registry
clinicaltrials.gov
Start Date
April 6, 2022
End Date
June 30, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Jhpiego
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Woman of reproductive age (18 to 49 years) seeking FP or ANC services at study sites
  • Women who believe they are able to conceive (i.e. who have not undergone a tubal ligation, hysterectomy, or oophorectomy, or are menopausal) (for FP clients)
  • Have a male partner they currently have sex with
  • Have a mobile phone that can be safely used for re-contacting for follow-up surveys
  • Do not have any accompanying male partners or family members aged 5 or above present

Exclusion Criteria

  • Any individuals that do not meet all of the above inclusion criteria or do not agree to participate in the study will be excluded from data collection.
  • In addition, individuals with impaired cognitive abilities (I.e. unable to make decisions/respond to questions on their own without assistance by someone else)will also be excluded from the data collection.
  • Finally, women who share a mobile phone with their partner/husband or another family member will also be excluded.

Outcomes

Primary Outcomes

Percentage of clients that report receiving a family planning method from healthcare provider

Time Frame: day of intervention

Change in percentage of clients disclosing exposure to intimate partner or sexual violence in past 3 months

Time Frame: baseline to 3-months and 6-months post-intervention

Disclosure will be defined by a positive response to either of the following questions: * Has your current partner ever slapped you, punched you, hit or kicked you, or done anything else to hurt you physically? * Has your current male partner ever forced you to have sex or do something sexual when you didn't want to?

Secondary Outcomes

  • Change in self-reported use of safety measures to protect respondent or her child/children from violence(baseline to 3-months and 6-months post-intervention)
  • Change in percentage of clients reporting experiences of reproductive coercion in 3 months prior to data collection(baseline to 3-months and 6-months post-intervention)
  • Change in percentage of clients demonstrating family planning self efficacy, as measured by Contraceptive Self-Efficacy among women in sub-Saharan Africa (CSESSA) sub-scale(baseline to 3-months and 6-months post-intervention)
  • Change in demonstrated self-efficacy to access IPV services(baseline to 3-months and 6-months post-intervention)

Study Sites (39)

Loading locations...

Similar Trials